Formulations of bendamustine

  • US 11,103,483 B2
  • Filed: 07/12/2019
  • Issued: 08/31/2021
  • Est. Priority Date: 01/28/2010
  • Status: Active Grant
First Claim
Patent Images

1. A ready to use liquid bendamustine-containing composition comprisingbendamustine, or a pharmaceutically acceptable salt thereof, wherein the bendamustine concentration in the composition is from about 10 mg/mL to about 100 mg/mL;

  • polyethylene glycol; and

    a stabilizing amount of an antioxidant;

    the composition having less than about 5% peak area response of total impurities resulting from the degradation of the bendamustine, as determined by HPLC as a wavelength of 223 nm after at least 15 months at a temperature of from about 5°

    C. to about 25°


View all claims

    Thank you for your feedback